Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
暂无分享,去创建一个
S. Iida | H. Nahi | V. De Stefano | K. Gries | J. Fastenau | M. Mateos | D. White | S. Usmani | M. Cavo | C. Hulin | N. Bahlis | C. Heuck | H. Magen | K. Lantz | X. Qin | T. Masterson | V. Hungria | H. Pei | M. Slavcev